Information
-
Trademark
-
97855620
-
International Classifications
-
Filing Date
March 24, 2023
a year ago
-
Transaction Date
July 16, 2024
5 months ago
-
Status Date
July 16, 2024
5 months ago
-
Published for Opposition Date
May 21, 2024
7 months ago
-
Location Date
July 16, 2024
5 months ago
-
Status Code
688
-
Current Location
INTENT TO USE SECTION
Employee Name
IN, SUNG HYUN
-
Attorney Docket Number
061884-400
Attorney Name
Karen Won
Law Office Assigned Location Code
L30
-
Owners
Mark Drawing Code
3
Mark Identification
SUTRO
Case File Statements
- GS0401: Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations
- DM0000: The mark consists of the word SUTRO with the letter O displayed as an elongated crescent with a circle placed in the open portion of the crescent.
- GS0051: Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer, cardiovascular, hematopoietic, central nervous system, autoimmune, infectious, skin and skin structure, bone, genetic, endocrine or metabolic diseases, disorders, and conditions; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use
- CC0000: Color is not claimed as a feature of the mark.
- GS0421: Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases
Case File Event Statements
-
3/28/2023 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/16/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/18/2023 - a year ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
12/19/2023 - a year ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/20/2023 - a year ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/20/2023 - a year ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
12/20/2023 - a year ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
3/19/2024 - 9 months ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/19/2024 - 9 months ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/19/2024 - 9 months ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/16/2024 - 8 months ago
11 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
4/16/2024 - 8 months ago
12 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
4/16/2024 - 8 months ago
13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
4/17/2024 - 8 months ago
15 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/1/2024 - 8 months ago
17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/21/2024 - 7 months ago
18 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/21/2024 - 7 months ago
19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/16/2024 - 5 months ago
20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
4/17/2024 - 8 months ago
14 - ASSIGNED TO LIE
Type: ALIE
-
4/17/2024 - 8 months ago
16 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA